1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Non-Hodgkin’s lymphoma: diagnosis and management

NICE guideline [NG52] Published: 20 July 2016

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Research recommendation(s) from an individual piece of guidance

Guidance:
Non-Hodgkin’s lymphoma: diagnosis and management
Date issued:
20 July 2016

Research recommendations coming out of this guidance

  • Baseline FDG-PET-CT imaging for people with diffuse large B-cell lymphoma stage II or above:- In people with diffuse large B-cell lymphoma stage II or above, does a baseline FDG-PET-CT scan have any advantages over a baseline CT scan in the correct interpretation of the end-of-treatment FDG-PET-CT scan?

  • Factors predicting outcomes for people with high-grade transformation of follicular lymphoma:- In people with high-grade transformation of follicular lymphoma, which biological and clinical factors predict good outcomes with immunochemotherapy alone?

  • Radiotherapy in first-line treatment of diffuse large B-cell lymphoma:- In people presenting with diffuse large B-cell lymphoma and sites of bulky disease, are outcomes improved by radiotherapy to those sites following a full course of chemotherapy?